Stocklytics Platform

Highest EBITDA

legend_toggle
Explore a diverse array of industries, each represented by companies that have excelled in generating substantial EBITDA.
name
PRICE $ CHANGE % CHANGE MARKET CAP VOLUME AVG. VOLUME arrow_downwardEBITDA TECHNICALS DIVIDEND Y ROI 1Y Score languageLAST 7 DAYS
Asset logo for symbol TYRA
TYRATyra Biosciences
$24.36$0.37arrow_drop_up1.54%$1.30B249.49K193.10K-$95.02MNeutralremove-65.82%AI Analysis
Asset logo for symbol SCLX
SCLXScilex Holding Company
$0.99-$0.03arrow_drop_down2.97%$144.23M1.08M952.06K-$95.02MNeutralremove--46.55%AI Analysis
Asset logo for symbol SCLXW
SCLXWScilex Holding Company
$0.29-$0.00arrow_drop_down3.30%_3.73K5.70K-$95.02MNeutralremove--44.23%AI Analysis
QSIA
QSIAWQuantum-Si incorporated
$0.08-$0.00arrow_drop_down9.19%_11.66K10.13K-$95.52MNeutralremove--69.95%AI Analysis
Asset logo for symbol QSI
QSIQuantum-Si incorporated
$0.97-$0.08arrow_drop_down7.84%$153.18M1.41M534.28K-$95.52MNeutralremove--53.48%AI Analysis
Asset logo for symbol IRTC
IRTCiRhythm Technologies
$70.00-$3.08arrow_drop_down4.21%$2.21B534.88K438.61K-$95.78MNeutralremove--25.14%AI Analysis
Asset logo for symbol ELVN
ELVNEnliven Therapeutics, Inc. - Common Stock
$23.19$0.12arrow_drop_up0.52%$1.02B662.14K193.13K-$95.95MNeutralremove-62.16%AI Analysis
Asset logo for symbol DZSI
DZSIDZS
$0.55-$0.05arrow_drop_down8.33%$22.06M101.0052.08K-$96.41MNeutralremove--77.27%AI Analysis
Asset logo for symbol NVTS
NVTSNavitas Semiconductor Corporation
$2.23-$0.17arrow_drop_down7.08%$435.71M3.37M2.82M-$96.42MNeutralremove--70.18%AI Analysis
Asset logo for symbol EYPT
EYPTEyePoint Pharmaceuticals
$8.91-$0.27arrow_drop_down2.94%$476.84M1.20M712.25K-$96.52MNeutralremove--5.01%AI Analysis
Asset logo for symbol LLAP
LLAPTerran Orbital Corporation
$0.24-$0.00arrow_drop_down1.41%$50.59M7.33M7.04M-$96.66MNeutralremove--78.55%AI Analysis
Asset logo for symbol ALT
ALTAltimmune
$7.79$0.22arrow_drop_up2.90%$528.05M2.98M2.85M-$96.88MNeutralremove-171.42%AI Analysis
Asset logo for symbol MRM
MRMMEDIROM Healthcare Technologies
$3.90-$0.08arrow_drop_down2.01%$19.65M4.30K9.99K-$97.26MNeutralremove--27.64%AI Analysis
Asset logo for symbol SLDB
SLDBSolid Biosciences
$7.86-$0.14arrow_drop_down1.75%$303.35M311.60K255.44K-$97.66MNeutralremove-172.91%AI Analysis
Asset logo for symbol FXLV
FXLVF45 Training Holdings
$0.30$0.000.00%$29.25M8.59K16.14K-$98.37MSellkeyboard_arrow_down-1,400.00%AI Analysis
Asset logo for symbol KZR
KZRKezar Life Sciences
$0.57-$0.01arrow_drop_down1.72%$42.05M182.78K295.18K-$98.46MNeutralremove--52.10%AI Analysis
Asset logo for symbol CABA
CABACabaletta Bio
$4.70$0.000.00%$218.84M2.71M1.12M-$98.61MNeutralremove--72.92%AI Analysis
Asset logo for symbol VSTM
VSTMVerastem
$2.89$0.06arrow_drop_up2.12%$109.06M604.30K450.49K-$98.76MNeutralremove--69.57%AI Analysis
Asset logo for symbol INDI
INDIindie Semiconductor
$3.64-$0.20arrow_drop_down5.20%$699.55M2.12M2.86M-$98.92MNeutralremove--42.85%AI Analysis
Asset logo for symbol AGEN
AGENAgenus
$5.86-$0.12arrow_drop_down2.08%$130.51M620.40K352.42K-$98.98MNeutralremove--76.35%AI Analysis
Showing 4661-4680 of 4977
Results per page:

About Highest EBITDA

Discover the stocks with the highest EBITDA, a significant financial metric indicating a company's operational profitability. EBITDA, or earnings before interest, taxes, depreciation, and amortization, reflects a firm's ability to generate profits from its core operations without factoring in financing and accounting decisions. Investors seek companies with robust EBITDA figures as it showcases their potential for sustainable growth and cash flow generation. High EBITDA stocks often demonstrate strong financial health and efficiency, making them attractive choices for long-term investment strategies.
toolkit image

Discover the Power of Stocklytics Tools

Our suite of tools empowers you to make informed decisions, seize opportunities, and stay ahead in the competitive trading world.

See Stocklytics Tools

Sign up for our newsletter

Join our exclusive community of over one million investment enthusiasts and receive our free newsletter filled with analysis, news, and updates every weekday.

Take Your Investments to a Whole New Level